InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Longpre Lara, Directeur du Développement. Director active across 1 companies, notably Mirum Pharmaceuticals, Inc.. Cumulatively, 9 disclosures have been recorded. The latest transaction was filed on 10 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
€18,7271,454 shares@ €12.87960.0005% mcap28.1% of flow
Common Stock
SEC:0001209191-22-028726:0·
010,000 shares0
Common Stock
SEC:0001209191-22-002428·
010,000 shares0
Common Stock
SEC:0001209191-22-002428:0·
€8,776753 shares@ €11.65530.0002% mcap36.7% of flow
Common Stock
SEC:0001209191-21-064449·
€8,776753 shares@ €11.65530.0002% mcap13.2% of flow
Common Stock
SEC:0001209191-21-064449:0·
08,125 shares0
Common Stock
SEC:0001209191-21-058606·
08,125 shares0
Common Stock
SEC:0001209191-21-058606:0·
€15,1611,259 shares@ €12.04190.0004% mcap63.3% of flow
Common Stock
SEC:0001209191-21-032154·
€15,1611,259 shares@ €12.04190.0004% mcap22.8% of flow
Common Stock
SEC:0001209191-21-032154:0·
9 of 9 declarations
About Longpre Lara
Lara Longpre is the Chief Development Officer at Mirum Pharmaceuticals, Inc. She is responsible for business development strategy and expanding the company's operations. Her expertise in the pharmaceutical sector is a major asset for the organization's growth.
